Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials.

Saved in:
Bibliographic Details
Title: Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials.
Authors: Askanase AD; Columbia University Irving Medical Center, New York University, New York City, New York, USA., Vital EM; University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Meier O; F. Hoffmann-La Roche Ltd, Basel, Switzerland oliver.meier.om2@roche.com., Turchetta A; Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada., Mao HA; Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada., Maller J; Genentech, Inc, South San Francisco, California, USA., Ross Terres JA; Genentech, Inc, South San Francisco, California, USA., Dall'Era M; University of California San Francisco, San Francisco, California, USA.
Source: Lupus science & medicine [Lupus Sci Med] 2025 May 19; Vol. 12 (1). Date of Electronic Publication: 2025 May 19.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2053-8790
DOI:10.1136/lupus-2024-001483